RT Journal Article
SR Electronic
T1 Phase 2 study of pembrolizumab in patients with advanced rare cancers
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e000347
DO 10.1136/jitc-2019-000347
VO 8
IS 1
A1 Naing, Aung
A1 Meric-Bernstam, Funda
A1 Stephen, Bettzy
A1 Karp, Daniel D
A1 Hajjar, Joud
A1 Rodon Ahnert, Jordi
A1 Piha-Paul, Sarina A
A1 Colen, Rivka R
A1 Jimenez, Camilo
A1 Raghav, Kanwal P
A1 Ferrarotto, Renata
A1 Tu, Shi-Ming
A1 Campbell, Matthew
A1 Wang, Linghua
A1 Sabir, Sarjeel H
A1 Tapia, Coya
A1 Bernatchez, Chantale
A1 Frumovitz, Michael
A1 Tannir, Nizar
A1 Ravi, Vinod
A1 Khan, Saria
A1 Painter, Jeane M
A1 Abonofal, Abulrahman
A1 Gong, Jing
A1 Alshawa, Anas
A1 McQuinn, Lacey M
A1 Xu, Mingxuan
A1 Ahmed, Sara
A1 Subbiah, Vivek
A1 Hong, David S
A1 Pant, Shubham
A1 Yap, Timothy A
A1 Tsimberidou, Apostolia M
A1 Dumbrava, Ecaterina E Ileana
A1 Janku, Filip
A1 Fu, Siqing
A1 Simon, Richard M
A1 Hess, Kenneth R
A1 Varadhachary, Gauri R
A1 Amir Habra, Mouhammed
YR 2020
UL http://jitc.bmj.com/content/8/1/e000347.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.